Search Results
Jul 15, 2026, 08:30 ET Nomadar Completes Acquisition of Land for the Development of JP Financial Arena
www.sec.gov. Further descriptions of these risks and uncertainties can be found in the Company's most recent Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 31, 2026, and in subsequent filings with and submissions to, the SEC, as
More news about: Nomadar
Jul 15, 2026, 08:06 ET Die Bank of America gibt die Finanzergebnisse für das zweite Quartal 2026 bekannt
Ein Formular 8-K mit den Finanzergebnissen der Bank of America ist auch auf der Website der U.S. Securities and Exchange Commission unter
More news about: Bank of America Corporation
Jul 15, 2026, 08:03 ET NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue
communities not adequately served by the large retail chains."Additional information on this transaction may be found in the Current Reports on Form 8-K that will be filed by NextPlat with the U.S. Securities and Exchange Commission (the "SEC").For more information about NextPlat, please visit
More news about: NextPlat Corp.
Jul 15, 2026, 07:45 ET Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
requirements and needs for additional financing; and other risks described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company's subsequent SEC filings, which can be obtained on the SEC website at
More news about: Intensity Therapeutics Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. 從 Bristol Myers Squibb 加拿大公司收購 CeeNU®（洛莫司汀）
Septa Pharmaceuticals Inc. 總裁兼首席執行官 Devinder K. 表示：「隨着我們將
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET 셉타 파마슈티컬스, 캐나다 브리스톨 마이어스 스퀴브에게 CeeNU® (Lomustine) 인수
CeeNU®(Lomustine)의 장기적인 공급 안정성을 최우선 과제로 두고 있다.데빈더 K.(Devinder K.)
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
(Lomustine) into our growing portfolio, our primary focus remains firmly on the patients and the medical professionals who treat them," said Devinder K., President & CEO of
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
(Lomustine) into our growing portfolio, our primary focus remains firmly on the patients and the medical professionals who treat them," said Devinder K., President & CEO of
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. erwirbt CeeNU®- e (Lomustin) von Bristol Myers Squibb, Kanada
Portfolio integrieren, liegt unser Hauptaugenmerk weiterhin fest auf den Patienten und den medizinischen Fachkräften, die sie behandeln", sagte Devinder K., Präsident und CEO von
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. Adquire CeeNU® (Lomustine) da Bristol Myers Squibb, Canadá
(Lomustine) em nosso portfólio crescente, nosso foco principal permanece firmemente nos pacientes e nos profissionais médicos que os tratam", disse Devinder K., presidente e CEO da
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. adquiere CeeNU® (Lomustina) de Bristol Myers Squibb, Canadá
nuestra creciente cartera, nuestro enfoque principal sigue siendo firmemente en los pacientes y los profesionales médicos que los tratan", dijo Devinder K., director general y consejero delegado de
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. Adquiere CeeNU® (Lomustine) de Bristol Myers Squibb, Canadá
nuestra creciente cartera, nuestro enfoque principal sigue siendo firmemente en los pacientes y los profesionales médicos que los tratan", dijo Devinder K., presidente y director ejecutivo de
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Septa Pharmaceuticals Inc. acquiert l' e CeeNU® (lomustine) auprès de Bristol Myers Squibb Canada
portefeuille en pleine expansion, notre priorité reste résolument les patients et les professionnels de santé qui les traitent », a déclaré Devinder K., président-directeur général d'
More news about: Septa Pharmaceuticals Inc.
Jul 15, 2026, 07:00 ET Withings BodyScan 2 Now Available in the US, Setting a Standard in Preventive Health and Longevity Monitoring
(AFib) detection features are medically regulated. These features are enabled in BodyScan 2 by Withings Scan Monitor 2.0, the FDA-cleared software (510(k) K230812) that powers ECG and AFib detection on the device — the clearance applies to this software, not to the BodyScan 2 hardware itself. All other features
More news about: Withings
Jul 15, 2026, 07:00 ET Freightos Reports Platform KPIs for Second Quarter Exceeding Management Expectations
earnings releasePlatform Expansion and Network GrowthTransactions: Q2 2026 transactions totaled a record 458k, up 15% year-over-year and above management's expectations, reflecting primarily resumed activity in Middle East routes. The military conflict in the
More news about: Freightos
Jul 15, 2026, 07:00 ET Full Circle Lithium Announces Upsize and Closing of First Tranche of Previously Announced Private Placement
July 15, 2026 /PRNewswire/ - Full Circle Lithium Corp. ("FCL" or the "Company") (TSXV: FCLI) (OTCQB: FCLIF) (FSE: K0Q), a leading U.S.-based manufacturer of lithium-ion battery fire extinguishing products, is pleased to announce the closing of the first tranche of its
More news about: Full Circle Lithium Inc
Jul 15, 2026, 07:00 ET Cypress Creek and Google Break Ground on America's Largest Solar Project
dedicated community investment funds.Google has committed $5 million in energy affordability initiatives to support local Arkansas residents and K-12 schools. This commitment builds on Google's existing Greater West Memphis Energy Impact Fund, supporting new community solar subscriptions in West
More news about: Cypress Creek Energy
Jul 15, 2026, 07:00 ET Hycroft Appoints Michael Deal as Chief Operating Officer
effect on our business, cash flows, financial condition and results of operations. Please see the "Risk Factors" outlined in our Annual Report on Form 10-K for the year ended December 31, 2025, and in other reports filed with the SEC, for more information about these and other risks.Given these risks
More news about: Hycroft Mining Holding Corporation
Jul 15, 2026, 06:56 ET Strategická modernizace značky GENMA přináší vynikající výsledky - řada významných zakázek a celosvětové uznání v oblasti automatizačních technologií
založeného na umělé inteligenci a správy digitálních dvojčat. Její plně automatizovaná technologie vnějšího odbavení kamionů je na špičce v oboru.K dnešnímu dni překročil celkový počet dodávek a smluvně sjednaných objednávek automatizovaných jeřábů a projektů modernizace společnosti GENMA 100 kusů,
More news about: RAINBOWCO
Jul 15, 2026, 06:41 ET RELEX Named a Leader in the 2026 Nucleus Research Enterprise Supply Chain Planning Value Matrix
capabilities on a single platform, to innovate at their own pace. Leading brands like ADUSA, Camco, Carhartt, COSMOS Pharmaceutical Corporation, Circle K, Dollar Tree and Family Dollar, M&S Food, PetSmart, Rituals, The Body Shop, The Home Depot, Ford South America, GEPP, Sun Tire & Auto Service,
More news about: RELEX Solutions
Jul 15, 2026, 06:40 ET BNY Declares Dividends
in a share of the Series J Preferred Stock);$1,537.50 per share on the Series K Preferred Stock (equivalent to $0.384375 per depositary share, each representing a 1/4,000th interest in a share of the Series K Preferred Stock); and$1,406.25 per share on the Series M Preferred Stock (equivalent
More news about: BNY
Jul 15, 2026, 06:32 ET PNC Reports Second Quarter 2026 Net Income of $2.1 Billion, $4.81 Diluted EPS or $4.85 as Adjusted
vendors and service providers specifically.We provide greater detail regarding these as well as other factors in our most recent Form 10-K and in any subsequent Form 10-Qs, including in the Risk Factors and Risk Management sections and the Legal Proceedings and Commitments Notes of the Notes
More news about: The PNC Financial Services Group, Inc.
Jul 15, 2026, 06:30 ET Hyperscale Data Expects to Sign AI Data Center and Neocloud Services Agreement with California-Based AI Company at Michigan Data Center Campus
results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at
More news about: Hyperscale Data Inc.
Jul 15, 2026, 06:30 ET First Horizon Corporation Delivers Strong Second Quarter 2026 Results with Net Income Available to Common Shareholders of $260 Million, up 12% year-over-year and EPS of $0.54, up $0.09 from Second Quarter 2025
document; in Items 2.02 and 7.01 of FHN's Current Report on Form 8-K filed with the Securities and Exchange Commission on the date of this release; in the forepart, and in Items 1, 1A, and 7, of FHN's most recent Annual Report on Form 10-K; and in the forepart, and in Item 1A of Part II, of FHN's Quarterly
More news about: First Horizon Corporation
Jul 15, 2026, 06:00 ET HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026
position HERV-K at the heart of biology that connects obesity, chronic inflammation, and cellular senescence, providing the first mechanistic and human plasma level evidence characterizing the pivotal role of HERV-K in the induction of adipocyte stress-associated inflammation. The detection of HERV-K reactivation
More news about: HERVolution Therapeutics